Lynsay Leighanne Brautnick, M.D.
Hematology & Oncology Physician · Fayetteville, AR
Lynsay Leighanne Brautnick, M.D. is a hematology & oncology physician with a practice address in Fayetteville, Arkansas, and NPI 1548317340, issued on Jan 4, 2007. Check the license (Arkansas E-6989, as entered in NPPES) on the Arkansas State Medical Board; the Medicare figures below come from public CMS files.
- Name
- Lynsay Leighanne Brautnick
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- E-6989 AR
Self-reported in NPPES; status is on the state search - Practice location
- 3232 N North Hills Blvd, Fayetteville, AR 72703
- Phone
- (479) 587-1700
- Enumerated
- Jan 4, 2007
- Record last updated
- Jul 6, 2026
- Fax
- (479) 587-1366
- Medicaid IDs
- 188522001 AR
1548317340 MO
200347920 A OK - Medicare enrollment
- Enrolled (PECOS I20110725000386); accepts Medicare assignment
- Medical or professional school
- University Of Texas Medical School At San Antonio, 2005
- Entity
- Type 1 · individual
Also registered at 3232 N North Hills Blvd
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Melanie Haney, APRNClinical Nurse Specialist1013324631
- Juan Lombeida, MDHospice and Palliative Medicine (Internal Medicine) Physician1043434202
Verify Lynsay Leighanne Brautnick in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersArkansas State Medical Board
Search for license E-6989Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.1 times the Medicare Part D claims of the average hematology & oncology physician in 2024
1,838 Medicare Part D claims for 343 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims. 122 claims were for opioids.
Most prescribed
- Ondansetron Odt119 claims
- Prochlorperazine Maleate103 claims
- Xarelto83 claims
- Levothyroxine Sodium73 claims
- Prednisone73 claims
- Creon62 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 87.7 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $883.53
64 payments; by number, the most common kind was food and beverage; the largest payer was Ipsen Biopharmaceuticals, Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Highlands Oncology Group PARogers, AR
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Hematology & Oncology Physician providers in Arkansas
There are 103 hematology & oncology physician records in Arkansas.
Other hematology & oncology physician records in Arkansas
- Isam Abdel-Karim, M.D.Fort Smith, AR1639359714
- Ali Abdelaal, MDHarrison, AR1255344131
- Imran Ahmad, MDLittle Rock, AR1346472669
- Jibran Ahmed, M.DLittle Rock, AR1780091975
- Jamie Lee AldakkourMountain Home, AR1366070179
- Konstantinos Arnaoutakis, M.D.Little Rock, AR1053426304
- K'Anne Arthur, MDFayetteville, AR1144663923
- Varant Arzoumanian, MDFort Smith, AR1790904027
- Alan Baltz, MDLittle Rock, AR1407352040
- Brad Baltz, MDLittle Rock, AR1164484614
Common questions
What is Lynsay Leighanne Brautnick, M.D.'s NPI number?
Lynsay Leighanne Brautnick, M.D.'s National Provider Identifier (NPI) is 1548317340, issued on Jan 4, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Lynsay Leighanne Brautnick, M.D. located?
The NPPES record lists a practice address at 3232 N North Hills Blvd, Fayetteville, AR, 72703. Phone: (479) 587-1700. Providers update this record themselves, so call before visiting.
How can I verify Lynsay Leighanne Brautnick, M.D.'s license?
NPPES lists Arkansas license number E-6989, as entered by the provider. Search the Arkansas State Medical Board at https://armedicalboard.adh.arkansas.gov/public/verify/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Lynsay Leighanne Brautnick, M.D. prescribe under Medicare Part D?
In 2024, Lynsay Leighanne Brautnick, M.D. had 1,838 Medicare Part D claims for 343 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Lynsay Leighanne Brautnick, M.D.'s MIPS final score?
The 2023 MIPS final score is 87.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.